News

High-dose Vitamin C may boost chemotherapy effectiveness

High-dose Vitamin C may boost chemotherapy effectiveness

February 11, 2014

High-doses of vitamin C delivered in conjunction with IV chemotherapy may boost chemotherapy’s effectiveness and reduce side-effects in ovarian cancer treatment, according to a new study published this week. Researchers from the University of Kansas Medical Center found that patients who received vitamin C in conjunction with the conventional chemotherapy drugs paclitaxel or carboplatin reported … Continued

Research

Regular Aspirin Use May Reduce Ovarian Cancer Risk

Regular Aspirin Use May Reduce Ovarian Cancer Risk

February 10, 2014

(February 10, 2014) Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by scientists at the National Cancer Institute (NCI).  However, further research is needed before clinical recommendations can be made. The study, which was conducted as part of the OCRF-funded Ovarian Cancer Association Consortium, … Continued

Research

Press Release: Ovarian Cancer Advocates Applaud Findings on...

Press Release: Ovarian Cancer Advocates Applaud Findings on Aspirin and Risk Reduction

February 7, 2014

FOR IMMEDIATE RELEASE: February 7, 2014 Further Study Needed Before Clinical Recommendations Change Washington, DC—A study published yesterday by the National Institutes of Health found that women who took aspirin on a daily basis had a 20 percent reduction in risk of ovarian cancer. The Ovarian Cancer National Alliance released the following statement in response … Continued

OCRA News

Study Shows 1 in 5 Women with Ovarian Cancer has Inherited ...

Study Shows 1 in 5 Women with Ovarian Cancer has Inherited Predisposition

January 31, 2014

(January 31, 2014)  A new study conservatively estimates that one in five women with ovarian cancer has inherited genetic mutations that increase the risk of the disease, according to research at Washington University School of Medicine in St. Louis. Most women in the study would have been unaware of a genetic predisposition to ovarian cancer because … Continued

Research

OCRF Research Finds New Factor in Ovarian Cancer Development

OCRF Research Finds New Factor in Ovarian Cancer Development

January 30, 2014

  (January 30, 2014)  OCRF grantee Yin Wang, PhD, led research which found that PKC iota signaling plays an important role in ovarian cancer development. The research, which was published in Molecular Cancer Research, also found that Auranofin,  a small molecular compound, shows potential for treating ovarian cancer. The research study was funded in part by … Continued

OCRA News

Partner Member Profile: Ovarian Cancer Alliance of Arizona

Partner Member Profile: Ovarian Cancer Alliance of Arizona

January 28, 2014

In 2008, a group of ovarian cancer patients and survivors created the Ovarian Cancer Alliance of Arizona. They were tired of the lack of resources in Arizona: no support network, no one to talk to outside of the doctor’s office, no extracurricular meetings or events, and no resources for caretakers. They started OCAZ to fill … Continued

Community

1 in 5 women with ovarian cancer have a genetic predisposition

1 in 5 women with ovarian cancer have a genetic predisposition

January 28, 2014

At least 20% of women with ovarian cancer have a genetic predisposition to the disease even if they don’t have a family history ovarian cancer, according to a recent study. Researchers at Washington University School of Medicine in St. Louis analyzed the genes in ovarian cancer tumor samples from over 400 women with no family … Continued

Research

Press Release: Cancer Advocates Debunk Huckabee’s Misleadin...

Press Release: Cancer Advocates Debunk Huckabee’s Misleading Comments on Oral Contraceptives

January 24, 2014

FOR IMMEDIATE RELEASE: January 24, 2014 Washington, DC—In response to a recent speech by Mike Huckabee, in which he stated that women use oral contraceptives because they “cannot control their libidos or their reproductive systems,” the Ovarian Cancer National Alliance issued the following statement from CEO Calaneet Balas: “In his quest for a quotable sound … Continued

Advocacy

2014 Ovarian Cancer Statistics

2014 Ovarian Cancer Statistics

January 22, 2014

(January 22, 2014) Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute, the Centers for Disease Control … Continued

Research

OCRFA Research Identifies Biomarker that May Predict Treatment Response

January 14, 2014

(January 13, 2014) Researchers at Case Western Reserve University, led by OCRFA grantee Analisa DiFeo, PhD have identified a microRNA biomarker that shows promise in predicting treatment response in the most common form of ovarian cancer – a finding that has the potential to improve outcomes for patients with the disease.  The findings were published … Continued

OCRA News

Ovarian Cancer Research Fund Awards a Record-Breaking $6.9 ...

Ovarian Cancer Research Fund Awards a Record-Breaking $6.9 Million in Grants

January 13, 2014

Kicks off 20th Anniversary with an unprecedented grant award for scientific research and gynecologic cancer patient support program New York, NY January 13, 2014 — To mark its 20th anniversary, Ovarian Cancer Research Fund has awarded a record-breaking $6.9 million in scientific research grants for ovarian cancer and program grants to support gynecologic cancer patients. … Continued

OCRA News

Meet OCRF’s 2014 Grant Recipients

Meet OCRF’s 2014 Grant Recipients

January 13, 2014

OCRF has awarded $6.5 million in research grants to 22 scientists at leading medical institutions across the country.

OCRA News